Clinical Trials
21 trialsNCT05385926 2024-02-05
Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT04870905 2023-03-06
Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Unknown
NCT04978012 2022-06-07
Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy
Fudan University
Phase 2 Unknown
NCT03854838 2022-04-29
IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.
Sun Yat-sen University
Phase 2 Unknown
NCT03129412 2020-09-17
Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT04476641 2020-07-20
DC-CIK
Sun Yat-sen University
Phase 2 Unknown
NCT04446663 2020-06-25
Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma
First People's Hospital of Foshan
Phase 2 Unknown
NCT03890185 2019-03-26
Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC
King Faisal Specialist Hospital & Research Center
Phase 2 Unknown
NCT02902432 2019-01-31
A Trial of Endostar in Patients With Carcinoma of the Head and Neck
China International Medical Foundation
Phase 2 Unknown
NCT03619824 2018-10-09
PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT01762514 2017-07-13
A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens
Sun Yat-sen University
Phase 2 Unknown
NCT02735317 2016-04-12
Efficacy and Safety of FORRADĀ® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Sun Yat-sen University
Phase 2 Unknown
NCT02729324 2016-04-06
Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRADĀ®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Sun Yat-sen University
Phase 2 Unknown
NCT02250599 2015-12-30
Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT01347424 2013-12-09
Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography
Sun Yat-sen University
Phase 2 Unknown
NCT00637637 2013-08-12
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01806272 2013-03-29
Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis
Sun Yat-sen University
Phase 2 Unknown
NCT01312311 2011-03-10
Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer
Samsung Medical Center
Phase 2 Unknown
NCT00363831 2010-07-28
Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
The University of Hong Kong
Phase 2 Unknown
NCT00004164 2009-02-09
Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00003327 2008-07-24
Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Unknown